The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study
Open accessAbstract
Aims/hypothesisThe FinnDiane Study has reported that mortality in type 1 diabetes is not increased over a 7 year follow-up in the absence of renal disease (RD). Using the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study population (n = 658) of childhood-onset type 1 diabetes (age <17 years), the present study sought to replicate and expand these findings to a 20 year follow-up (as of 1 January 2008) and examine cause of death by renal status.MethodsAt baseline (1986–1988), mean age and duration of diabetes were 28 and 19 years, respectively. RD was defined as an albumin excretion rate ≥20 μg/min from multiple samples and grouped as microalbuminuria (MA; 20–200 μg/min), overt nephropathy (ON; >200 μg/min), or end stage renal disease (ESRD; dialysis or renal transplantation).ResultsAt baseline, 311 (47.3%) individuals had RD (MA 21.3%, ON 22.2% and ESRD 3.8%). During a median 20 year follow-up, there were 152 deaths (23.1%). Mortality was 6.2 (95% CI 5.2–7.2) times higher than expected, with standardised mortality ratios of 2.0 (1.2–2.8) for normoalbuminuria (NA); 6.4 (4.4–8.4) for MA; 12.5 (9.5–15.4) for ON; and 29.8 (16.8–42.9) for ESRD. Excluding those (n = 64) with NA who later progressed to RD, no significant excess mortality was observed in the remaining NA group (1.2, 0.5–1.9), whose deaths were largely unrelated to diabetes.Conclusions/interpretationThese data confirm the importance of RD, including persistent microalbuminuria, as a marker of mortality risk and suggest that type 1 diabetes patients without renal disease achieve long-term survival comparable to the general population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Levey, A. S., Coresh, J., Greene, T., Marsh, J., Stevens, L. A., Kusek, J. W., Van Lente, F., & for Chronic Kidney Disease Epidemiology Collaboration (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077180 · Cited by 1,855
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes · doi:10.2337/db05-1620 · Cited by 927
(2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.193 · Cited by 653 · cited 2×
“Thus, these data partially reflect outdated diabetes management and care, and may not be generalisable to individuals recently diagnosed with type 1 diabetes, whose experience may more closely resemble that of the DCCT intensive therapy cohort, as recently described [28].”
ResultCan clinical factors estimate insulin resistance in type 1 diabetes?
Williams, K. V., Erbey, J. R., Becker, D., Arslanian, S., & Orchard, T. J. (2000) · Diabetes · doi:10.2337/diabetes.49.4.626 · Cited by 640 · cited 1×
“Insulin sensitivity was estimated using a regression equation for glucose disposal rate (eGDR) derived from hyperinsulinaemic–euglycaemic clamp studies, as previously described [13].”
MethodThe presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638 · cited 5×
“Our results confirm and expand, with longer follow-up, previously published findings by the FinnDiane group [8] demonstrating that, in the absence of renal disease, individuals with type 1 diabetes experience mortality rates similar to those in the general population.”
BackgroundMethodResultInfluentialKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 1×
“It has long been known that the development of overt nephropathy in type 1 diabetes carries excess mortality risk [17], although the importance of microalbuminuria has been less clear, both because of its often transient nature and also because its sensitivity in identifying those at risk of progressive renal function…”
BackgroundOrchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Drash, A. L., Ellis, D., LaPorte, R. E., & Kuller, L. H. (1990) · Diabetes · doi:10.2337/diab.39.9.1116 · Cited by 540
Self-citationThe 30-Year Natural History of Type 1 Diabetes Complications
Pambianco, G., Costacou, T., Ellis, D., Becker, D. J., Klein, R., & Orchard, T. J. (2006) · Diabetes · doi:10.2337/db05-1423 · Cited by 493
Self-citationOrchard, T. J., Olson, J. C., Erbey, J. R., Williams, K., Forrest, K. Y.-Z., Smithline Kinder, L., Ellis, D., & Becker, D. J. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1374 · Cited by 492 · cited 2×
“Nonetheless, we have previously shown that overt nephropathy is a strong independent risk factor for incident ‘hard’ coronary artery disease (CAD) events (but not total CAD), even after allowing for standard risk factors, including lipid and BP levels, as well as a measure of insulin resistance [25].”
BackgroundSelf-citationPredictors of mortality in insulin dependent diabetes: 10 year observational follow up study
Rossing, P., Hougaard, P., Borch-Johnsen, K., & Parving, H.-H. (1996) · BMJ · doi:10.1136/bmj.313.7060.779 · Cited by 428
Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 376
Messent, J. W. C., Elliott, T. G., Hill, R. D., Jarrett, R. J., Keen, H., & Viberti, G. (1992) · Kidney International · doi:10.1038/ki.1992.128 · Cited by 328
Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1098 · Cited by 306
Orchard, T. J., Chang, Y.-F., Ferrell, R. E., Petro, N., & Ellis, D. E. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00507.x · Cited by 239
Self-citationWagener, D. K., Sacks, J. M., LaPorte, R. E., & MaCgregor, J. M. (1982) · Diabetes · doi:10.2337/diab.31.2.136 · Cited by 218
Orchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Ellis, D., LaPorte, R. E., Kuller, L. H., Wolfson, S. K., & Drash, A. L. (1990) · Diabetes Care · doi:10.2337/diacare.13.7.741 · Cited by 207
Self-citationPambianco, G., Costacou, T., & Orchard, T. J. (2007) · Diabetes Care · doi:10.2337/dc06-2053 · Cited by 198 · cited 7×
“Fasting blood samples were taken to measure glycosylated haemoglobin (HbA1), lipids and lipoproteins.”
BackgroundInfluentialSelf-citationWarnick, G. R., & Albers, J. J. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.6.900 · Cited by 179
Mortality Trends in Type 1 Diabetes
Nishimura, R., LaPorte, R. E., Dorman, J. S., Tajima, N., Becker, D., & Orchard, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.823 · Cited by 174
Self-citationPredictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
Forsblom, C. M., Groop, P. H., Ekstrand, A., & Groop, L. C. (1992) · BMJ · doi:10.1136/bmj.305.6861.1051 · Cited by 162
Khwāmthukyāk, K. L. (2003) · Medical Entomology and Zoology · Cited by 146
Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland
Asao, K., Sarti, C., Forsen, T., Hyttinen, V., Nishimura, R., Matsushima, M., Reunanen, A., Tuomilehto, J., Tajima, N., & for the Diabetes Epidemiology Research International (DERI) Mortality Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2037 · Cited by 102
International Evaluation of Cause-Specific Mortality and IDDM
Diabetes Epidemiology Research International Mortality Study Group (1991) · Diabetes Care · doi:10.2337/diacare.14.1.55 · Cited by 97
Ellis, D., Coonrod, B. A., Dorman, J. S., Kelsey, S. F., Becker, D. J., Avner, E. D., & Orchard, T. J. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80039-3 · Cited by 89
Self-citationProgression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule
Vergouwe, Y., Soedamah‐Muthu, S. S., Zgibor, J. C., Chaturvedi, N., Forsblom, C. M., Snell‐Bergeon, J. K., Maahs, D. M., Groop, P., Rewers, M., Orchard, T. J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1585-3 · Cited by 69
Self-citationMicroalbuminuria and Mortality in Long-Duration Type 1 Diabetes
Allen, K. V., & Walker, J. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2389 · Cited by 68
Costacou, T., Ellis, D., Fried, L. F., & Orchard, T. J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.08.005 · Cited by 66
Self-citationSignificance of Microalbuminuria in Long-Duration Type 1 Diabetes
Arun, C. S., Stoddart, J., Mackin, P., MacLeod, J. M., New, J. P., & Marshall, S. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2144 · Cited by 43
Comparing standardized mortality ratios
Armstrong, B. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00032-o · Cited by 35
Cited by
Kidney disease and increased mortality risk in type 2 diabetes
Afkarian, M., Sachs, M. C., Kestenbaum, B., Hirsch, I. B., Tuttle, K. R., Himmelfarb, J., & de Boer, I. H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012070718 · Cited by 1,298
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Temporal trends in the prevalence of diabetic kidney disease in the United States
de Boer, I. H. (2011) · JAMA · doi:10.1001/jama.2011.861 · Cited by 1,036
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686
Metadata
- Authors
- Orchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T.
- Venue
- Diabetologia
- Published
- 2010-07-28
- Volume
- 53
- Issue
- 11
- Pages
- 2312-2319
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2121633948
- Cited by
- 313
- References
- 31
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.